| 000 | 01043 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515112822.0 | ||
| 264 | 0 | _c20100810 | |
| 008 | 201008s 0 0 spa d | ||
| 022 | _a1578-2190 | ||
| 024 | 7 |
_a10.1016/s0001-7310(08)76192-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVanaclocha Sebastián, F | |
| 245 | 0 | 0 |
_a[PROLOGO: efalizumab]. _h[electronic resource] |
| 260 |
_bActas dermo-sifiliograficas _cJan 2008 |
||
| 300 |
_a1 p. _bdigital |
||
| 500 | _aPublication Type: Introductory Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
| 650 | 0 | 4 |
_aCD11a Antigen _ximmunology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPsoriasis _xtherapy |
| 773 | 0 |
_tActas dermo-sifiliograficas _gvol. 99 Suppl 1 _gp. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0001-7310(08)76192-1 _zAvailable from publisher's website |
| 999 |
_c17843466 _d17843466 |
||